Possible role of anti-TNF monoclonal antibodies in the treatment of Mycobacterium marinum infection

Rheumatology

Volumn 49, Issue 10, 2010, Pages 1991-1993

  Garzoni, Christian ^a   Adler, Sabine ^a   Boller, Christoph ^a   Furrer, HansJakob ^a   Villiger, Peter M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETANERCEPT; ETHAMBUTOL; GAMMA INTERFERON; GLUCOCORTICOID; INFLIXIMAB; ISONIAZID; METHOTREXATE; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRITIS; BACKACHE; CASE REPORT; CHRONIC INFLAMMATION; DACTYLOLYSIS; DRUG WITHDRAWAL; FISTULA; GRANULOMA; HUMAN; LATENT TUBERCULOSIS; LETTER; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM MARINUM; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SYNOVITIS; TENOSYNOVITIS;

ADULT; ANTIBODIES, MONOCLONAL; HUMANS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; TREATMENT OUTCOME;

EID: 77956842189     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq146     Document Type: Letter

References (10)

1. Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002;162: 1746-52.
2. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.
3. Dare JA, Jahan S, Hiatt K, Torralba KD. Reintroduction of etanercept during treatment of cutaneous Mycobacterium marinum infection in a patient with ankylosing spondylitis. Arthritis Rheum 2009;61:583-6.
4. Villiger PM, Zellweger J-P, Moeller B. Novel screening tools for latent tuberculosis: time to leave an old friend? Curr Opin Rheumatol 2009;21:238-43.
5. Arend SM, van Meijgaarden KE, de Boer K et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002; 186:1797-807.
6. Thomsen VO, Kok-Jensen A, Buser M, Philippi-Schulz S, Burkhardt HJ. Monitoring of patients with pulmonary tuberculosis: can PCR be applied? J Clin Microbiol 1999;37: 3601-7.
7. Wallis RS, van Vuuren C, Potgieter S. Adalimumab treatment of life-threatening tuberculosis. Clin Infect Dis 2009; 48:1429-32.
8. Wallis RS. Infectious complications of tumor necrosis factor blockade. Curr Opin Infect Dis 2009;22:403-9.
9. Rallis E, Koumantaki-Mathioudaki E, Frangoulis E, Chatziolou E, Katsambas A. Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 2007;8:385-8.
10. Chopra N, Kirschenbaum AE, Widman D. Mycobacterium marinum tenosynovitis in a patient on etanercept therapy for rheumatoid arthritis. J Clin Rheumatol 2002;8:265-8.